- Q2 2024 Nykode Therapeutics ASA Earnings Call Transcript5 days agokr18.69Earnings
- Q1 2024 Nykode Therapeutics ASA Earnings Call TranscriptMay 14, 2024kr18.69Earnings
- Q4 2023 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2024kr18.69Earnings
- Q2 2023 Nykode Therapeutics ASA Earnings Call TranscriptAug 23, 2023Earnings
- Nykode Therapeutics ASA at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Nykode Therapeutics ASA Earnings Call TranscriptMay 12, 2023Earnings
- Q4 2022 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2023Earnings
- Nykode Therapeutics ASA Corporate Call TranscriptDec 20, 2022
- Q3 2022 Nykode Therapeutics ASA Earnings Call TranscriptNov 23, 2022Earnings
- Nykode Therapeutics ASA at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Nykode Therapeutics AS at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Vaccibody AS Call to Discuss License Agreement with Adaptive Biotechnologies Corp TranscriptJul 12, 2021
Nykode Therapeutics ASA Corporate Call Transcript
Greetings and welcome to the Nykode Therapeutics webcast. At this time, all participants are in a listen-only mode. A web question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.
I would now like to turn the call over to Chief Executive Officer, Michael Engsig. Thank you. You may begin.
Thank you very much. And again, a warm welcome to everybody. Good morning to the US. We are very, very excited to take you through our plans for the VB10.16 asset, which we have disclosed today.
And just a quick note on the forward-looking statements. We assume you are forward -- or familiar with these statements. On that note, we'll quickly move on.
With me today I have in the room, Agnete Fredriksen, our Co-Founder and Chief Business Officer; and Klaus Edvardsen, our Chief Development Officer. And Klaus will take you into a deeper dive on the on the VB10.16 development plans as well as the rationale of our plans.
But before handing over
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)